Related references
Note: Only part of the references are listed.Coronavirus disease 2019 in patients with inborn errors of immunity: An international study
Isabelle Meyts et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency
Samaneh Delavari et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
M. J. Joyner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
V. A. Simonovich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Delphine Sterlin et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis
Stephen A. Klassen et al.
MAYO CLINIC PROCEEDINGS (2021)
Longitudinal analysis of SARS-CoV-2 antibodies in 8000 US first-time convalescent plasma donations
Michael Karbiener et al.
TRANSFUSION (2021)
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays
Gregory J. Walker et al.
VIRUSES-BASEL (2021)
Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
Stephane Marot et al.
NATURE COMMUNICATIONS (2021)
The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19
Daniele Focosi et al.
LIFE-BASEL (2021)
Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma
Shaukat Ali et al.
IMMUNOTHERAPY (2021)
Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency
Hannah Kinoshita et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2021)
Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic
Maria R. Farcet et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
WHO International Standard for anti-SARS-CoV-2 immunoglobulin
Paul A. Kristiansen et al.
LANCET (2021)
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos et al.
SCIENCE (2021)
Brief report: Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma
Peter Vandeberg et al.
TRANSFUSION (2021)
Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID-19 convalescent plasma donors
Molly A. Vickers et al.
TRANSFUSION (2021)
Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)
David Tougeron et al.
EUROPEAN JOURNAL OF CANCER (2021)
Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities
Myron S. Cohen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021
Jefferson M. Jones et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
David Hagin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Rita E. Chen et al.
NATURE (2021)
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
Heather Kalish et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
Henry T. Peng et al.
JMIR PUBLIC HEALTH AND SURVEILLANCE (2021)
Evaluation of 3 SARS-CoV-2 IgG Antibody Assays and Correlation with Neutralizing Antibodies
Jenna Rychert et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2021)
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
Alison Tarke et al.
CELL REPORTS MEDICINE (2021)
Convalescent plasma as a potential therapy for COVID-19
Long Chen et al.
LANCET INFECTIOUS DISEASES (2020)
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation
A. J. Jaaskelainen et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Characteristics and serological patterns ofCOVID-19 convalescent plasma donors: optimal donors and timing of donation
Ling Li et al.
TRANSFUSION (2020)
Treatment for emerging viruses: Convalescent plasma and COVID-19
Bethany L. Brown et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
Jose Maria Diez et al.
IMMUNOTHERAPY (2020)
Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study
Isaac R. Melamed et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid
Kai Uwe Radomski et al.
BIODRUGS (2017)
Tolerability and safety of Octagam® (IVIG): a post-authorization safety analysis of four non-interventional phase IV trials
Wolfgang Frenzel et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2016)
Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study
Marcel A. Mueller et al.
LANCET INFECTIOUS DISEASES (2015)
Primary antibody deficiencies
Anne Durandy et al.
NATURE REVIEWS IMMUNOLOGY (2013)
An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system
Klaus K. Orlinger et al.
VACCINE (2010)
Fast Implementation for Normal Mixed Effects Models With Censored Response
Florin Vaida et al.
JOURNAL OF COMPUTATIONAL AND GRAPHICAL STATISTICS (2009)
Pharmacokinetics of Immunoglobulin Administered via Intravenous or Subcutaneous Routes
Francisco A. Bonilla
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2008)